Income Statement

KEROS THERAPEUTICS, INC.

KROS
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Revenue
244.06 3.55 0.15 0.00 20.10 0.00
Cost of Revenue
- - - - - -
Gross Profit
244.06 3.55 0.15 - 20.10 -
Operating Expenses
176.49 214.38 170.09 114.79 76.47 46.66
Research & Development
129.64 173.63 135.26 87.27 55.14 33.86
Selling, General & Administrative
46.85 40.75 34.83 27.53 21.33 12.80
Other Operating Expenses
- - - - - -
Operating Income
67.57 -210.83 -169.94 -114.79 -56.37 -46.66
Non-Operating Income
24.33 23.78 16.95 10.11 -0.36 1.12
Interest Income
- - - - - -
Interest Expense
- 0.00 0.00 0.00 0.00 -
Other Non-Op Income / Expense
-0.54 -0.95 -0.21 3.03 -0.36 0.16
Income Before Tax
91.90 -187.05 -152.99 -104.68 -56.73 -45.53
Income Tax Expense
4.88 0.30 0.00 0.00 2.01 -0.17
Non-Controlling Interest
- - - - - -
Net Income
87.01 -187.35 -152.99 -104.68 -58.74 -45.36
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Depreciation & Amortization
- - - - - -
EBITDA
67.57 -210.83 -169.94 -114.79 -56.37 -46.66
Earnings Per Share (Basic)
2.34 -5.00 -5.20 -4.15 -2.52 -
Diluted EPS
2.30 -5.00 -5.20 -4.15 -2.52 -
Weighted Average Shares
37.22 37.44 29.45 25.24 23.33 -
Diluted Weighted Avg Shares
37.86 37.44 29.45 25.24 23.33 -
Comprehensive Income
- - - - - -